“Patients who choose a market basket of brand-name drugs instead of clinically equivalent generic alternatives are being charged a higher premium for this decision than ever before. That larger-than-necessary cost is being shared across the member and the plan sponsor. Both can realize savings when members choose lower-cost therapeutically equivalent generic drugs.”
— Sharon Frazee, Ph.D., VP for research and new solutions at Express Scripts, told AIS’s Drug Benefit News.
At Medicare is Simple, we look to educate and enable you to choose among Medicare plans to help find the policy that may best fit your needs. Get free quotes using our advanced quoting technology. HealthCare Reform is also a hot topic of interest to people of all ages, and we look to keep you updated on the issues relevant to learning more. Medicare Is Simple 800-442-4915
No comments:
Post a Comment